Treatment options in newly diagnosed NLPHL. *Patients with early-stage NLPHL except for stage IA with no clinical risk factors. †Four cycles of escalated BEACOPP (BEACOPPesc) in case of  interim PET after 2 cycles of chemotherapy with escalated BEACOPP (PET-2) negativity, 6 cycles of BEACOPPesc in case of PET-2 positivity. ‡Can be considered in patients with a CR according to PET and CT imaging after lymph node resection. §Can be considered in patients with conditions precluding the use of anthracyclines.
Figure 1.

Treatment options in newly diagnosed NLPHL. *Patients with early-stage NLPHL except for stage IA with no clinical risk factors. †Four cycles of escalated BEACOPP (BEACOPPesc) in case of  interim PET after 2 cycles of chemotherapy with escalated BEACOPP (PET-2) negativity, 6 cycles of BEACOPPesc in case of PET-2 positivity. ‡Can be considered in patients with a CR according to PET and CT imaging after lymph node resection. §Can be considered in patients with conditions precluding the use of anthracyclines.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal